Tag: PDF

ST. JOHN'S, Newfoundland and Labrador, July 24, 2025 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its second quarter 2025 financial results on Friday, August 1, 2025. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation's second quarter financial results.

_{⁽¹⁾ Volume is measured on a standard physical case basis and is used to standardize differing package configurations delivered via direct store delivery.}

Solid results in the first half of 2025
despite the prevailing environment
. Revenue: €40 billion
. Profit from recurring operations: €9 billion
. Free cash flow: €4 billion

PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx^® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.